One of Bristol-Myers’s largest shareholders is opposing the company’s $74 billion deal to buy rival Celgene, becoming the latest investor to express its unhappiness with the transaction.
from WSJ.com: US Business https://ift.tt/2Vp3T2t
Subscribe to:
Post Comments (Atom)
For brain surgery patients, a robot could be the key to faster recovery
A neurosurgeon removed a patient's brain tumor using robotic arms. SIP/Universal Images Group via Getty Images; Alyssa Powell/BI Dr...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
-
Student-loan borrowers said they're worried about higher payments without the SAVE plan. Aaron Hawkins/Getty Images/iStockphoto Tru...
No comments:
Post a Comment